Ascendis Pharma A/S

IPO

Ascendis Pharma: Patients. Science. Passion.

Public · Hellerup, Denmark · Founded 2007 · $85.7M raised

Headquarters
Hellerup
Employees
501–1000
Founded
2007
Business Model
B2B
Total Funding
$85.7M
Last Round
$60.0M SeedDec 2014
Rounds
3
Type
Public

About

Clinical-stage biopharmaceutical company developing TransCon therapeutic platforms targeting rare diseases and endocrinology.

Summary

Ascendis Pharma A/S is a Biotech company based in Hellerup, Denmark, founded in 2007. It has raised $85.7M in total across 3 rounds, most recently a $60.0M Seed round in Dec 2014. Investors include Sofinnova Partners, OrbiMed and Gilde Healthcare.

Tech & App Stack

7 technologies & apps tracked

Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.

Sign up to view the funding chart

Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.

Funding History

IPOJan 2015
$124.2M

Sign up to see all 4 rounds

Full funding history, per-round amounts, and investor participation.

Investors

Similar Companies